PL2604629T3 - Kompozycja do zapobiegania lub leczenia raka szyjki macicy ze wzmacniaczem odporności przeciwko wirusowi brodawczaka ludzkiego - Google Patents
Kompozycja do zapobiegania lub leczenia raka szyjki macicy ze wzmacniaczem odporności przeciwko wirusowi brodawczaka ludzkiegoInfo
- Publication number
- PL2604629T3 PL2604629T3 PL10855938T PL10855938T PL2604629T3 PL 2604629 T3 PL2604629 T3 PL 2604629T3 PL 10855938 T PL10855938 T PL 10855938T PL 10855938 T PL10855938 T PL 10855938T PL 2604629 T3 PL2604629 T3 PL 2604629T3
- Authority
- PL
- Poland
- Prior art keywords
- preventing
- composition
- cervical cancer
- human papillomavirus
- treating cervical
- Prior art date
Links
- 206010008342 Cervix carcinoma Diseases 0.000 title 1
- 241000701806 Human papillomavirus Species 0.000 title 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 title 1
- 201000010881 cervical cancer Diseases 0.000 title 1
- 239000003623 enhancer Substances 0.000 title 1
- 230000036039 immunity Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2010/005367 WO2012020871A1 (ko) | 2010-08-13 | 2010-08-13 | 사람 파필로마바이러스 변형체 및 면역 증강제를 포함하는 자궁경부암 예방 또는 치료용 조성물 |
| EP10855938.6A EP2604629B1 (en) | 2010-08-13 | 2010-08-13 | Composition for preventing or treating cervical cancer having human papillomavirus immunity enhancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2604629T3 true PL2604629T3 (pl) | 2018-08-31 |
Family
ID=45567817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10855938T PL2604629T3 (pl) | 2010-08-13 | 2010-08-13 | Kompozycja do zapobiegania lub leczenia raka szyjki macicy ze wzmacniaczem odporności przeciwko wirusowi brodawczaka ludzkiego |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9000139B2 (pl) |
| EP (1) | EP2604629B1 (pl) |
| JP (1) | JP5740473B2 (pl) |
| CN (1) | CN103180343B (pl) |
| ES (1) | ES2666720T3 (pl) |
| PL (1) | PL2604629T3 (pl) |
| WO (1) | WO2012020871A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2604629T3 (pl) | 2010-08-13 | 2018-08-31 | Genexine, Inc. | Kompozycja do zapobiegania lub leczenia raka szyjki macicy ze wzmacniaczem odporności przeciwko wirusowi brodawczaka ludzkiego |
| CN103740741B (zh) * | 2014-01-22 | 2016-08-17 | 北京工业大学 | Hpv18 e6和e7融合基因突变体及其相关生物材料与编码蛋白 |
| MX2017002081A (es) | 2014-08-15 | 2017-05-23 | Genexine Inc | Metodo para tratar cancer de cuello uterino. |
| HUE040440T2 (hu) * | 2014-11-04 | 2019-03-28 | Janssen Vaccines & Prevention Bv | Terápiás HPV16-oltóanyagok |
| CN105753989A (zh) * | 2014-12-15 | 2016-07-13 | 牛津疫苗医学生物科技（英国）有限公司 | 人工多抗原融合蛋白及其制备和应用 |
| WO2017096432A1 (en) * | 2015-12-09 | 2017-06-15 | Admedus Vaccines Pty Ltd | Immunomodulating composition for treatment |
| CN106632694B (zh) * | 2017-01-24 | 2021-02-12 | 南京益康生物医药有限公司 | 一种重组蛋白及药物组合物与应用 |
| PH12022552820A1 (en) * | 2020-04-24 | 2024-03-25 | Genexine Inc | Method for treating cervical cancer |
| US12485165B2 (en) | 2022-01-18 | 2025-12-02 | Papivax Biotech Inc. | Vaccine combination and method for using the same |
| JP7385684B2 (ja) * | 2022-01-18 | 2023-11-22 | パピヴァックス バイオテック インコーポレイテッド | ワクチンの組み合わせ及びその使用方法 |
| US20250188182A1 (en) | 2022-03-10 | 2025-06-12 | Genexine, Inc. | Triple combination drug dosing therapy for head and neck cancer treatment |
| AU2023414262B2 (en) | 2022-12-29 | 2025-08-14 | Rinuagene Biotechnology Co., Ltd. | Polynucleotide molecule for preventing or treating hpv infection-related diseases |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN015794A0 (en) | 1994-12-20 | 1995-01-19 | Csl Limited | Variants of human papilloma virus antigens |
| KR100201584B1 (ko) * | 1996-07-12 | 1999-06-15 | 손경식 | 사람 파필로마 바이러스 18형 이6 단백질에 대한 인체의 면역성 조절 기능을 갖는 펩타이드 |
| GB9717953D0 (en) | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
| EP2100620A1 (en) * | 1999-09-16 | 2009-09-16 | Eisai Corporation of North America | Nucleic acids encoding polyepitope polypeptides |
| ES2284559T3 (es) * | 2001-03-23 | 2007-11-16 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Genes y proteinas e6 y e7 modificados del vph utiles como vacuna. |
| KR100900249B1 (ko) | 2001-12-07 | 2009-05-29 | 포항공과대학교 산학협력단 | ＳＩＶｍａｃ239의 면역원성 플라스미드 및 이들을 함유한ＡＩＤＳ ＤＮＡ 백신 |
| MXPA05003395A (es) | 2002-10-03 | 2005-06-22 | Wyeth Corp | Polipeptidos de virus de papiloma humano y composiciones inmunogenas. |
| CN1299769C (zh) * | 2005-01-31 | 2007-02-14 | 中国医学科学院肿瘤医院肿瘤研究所 | 人乳头瘤病毒和热休克蛋白重组蛋白疫苗及其用途 |
| EP1757615B1 (en) * | 2005-08-24 | 2011-08-24 | Healthbanks Biotech Co., Ltd. | Fusion protein for inhibiting cervical cancer |
| CN101421306B (zh) * | 2006-04-19 | 2013-09-18 | 浦项工科大学校产学协力团 | 用于治疗和预防子宫颈癌的包含hpv多肽和免疫增强肽的组合物 |
| DE102008010954A1 (de) * | 2008-02-25 | 2009-08-27 | Cichon, Günter, Prof.Dr. | DNA-Vakzine zur Therapie und Prophylaxe von Gebärmutterhalskrebs und seinen prämalignen Vorstufen |
| PL2604629T3 (pl) | 2010-08-13 | 2018-08-31 | Genexine, Inc. | Kompozycja do zapobiegania lub leczenia raka szyjki macicy ze wzmacniaczem odporności przeciwko wirusowi brodawczaka ludzkiego |
-
2010
- 2010-08-13 PL PL10855938T patent/PL2604629T3/pl unknown
- 2010-08-13 ES ES10855938.6T patent/ES2666720T3/es active Active
- 2010-08-13 US US13/816,716 patent/US9000139B2/en active Active
- 2010-08-13 EP EP10855938.6A patent/EP2604629B1/en active Active
- 2010-08-13 WO PCT/KR2010/005367 patent/WO2012020871A1/ko not_active Ceased
- 2010-08-13 CN CN201080068626.6A patent/CN103180343B/zh active Active
- 2010-08-13 JP JP2013524762A patent/JP5740473B2/ja active Active
-
2015
- 2015-03-03 US US14/636,745 patent/US9399665B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2604629A1 (en) | 2013-06-19 |
| CN103180343B (zh) | 2016-01-20 |
| EP2604629B1 (en) | 2018-02-28 |
| WO2012020871A1 (ko) | 2012-02-16 |
| JP2013537422A (ja) | 2013-10-03 |
| JP5740473B2 (ja) | 2015-06-24 |
| US9000139B2 (en) | 2015-04-07 |
| ES2666720T3 (es) | 2018-05-07 |
| US20130195905A1 (en) | 2013-08-01 |
| CN103180343A (zh) | 2013-06-26 |
| EP2604629A4 (en) | 2014-01-15 |
| US9399665B2 (en) | 2016-07-26 |
| US20150239939A1 (en) | 2015-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2604629T3 (pl) | Kompozycja do zapobiegania lub leczenia raka szyjki macicy ze wzmacniaczem odporności przeciwko wirusowi brodawczaka ludzkiego | |
| PL2532680T3 (pl) | Kompozycja medyczna do leczenia raka i/lub zapobiegania | |
| PL2532366T3 (pl) | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi | |
| PL2740793T3 (pl) | Kompozycja leku do leczenia i/lub zapobiegania nowotworowi | |
| PL2740795T3 (pl) | Kompozycja lekowa do leczenia nowotworu i/lub zapobiegania nowotworowi | |
| PL2740798T3 (pl) | Kompozycja leku do leczenia i/lub zapobiegania nowotworom | |
| SG10201509279QA (en) | Compositions and methods for the prevention and treatment of cancer | |
| ZA201207574B (en) | Phytocannabinoids in the treatment of cancer | |
| PL2532365T3 (pl) | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi | |
| PL2532743T3 (pl) | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania raka | |
| IL214746A0 (en) | Substituted pyrimidines for the treatment of cancer | |
| IL251083A0 (en) | Compounds and preparations for the treatment of cancer | |
| SG10201508495VA (en) | Combination treatment of cancer | |
| ZA201208413B (en) | Skin treatment composition | |
| SG173672A1 (en) | Novel ortho-aminoamides for the treatment of cancer | |
| GB2497899B (en) | Sanguiin for use in the prevention or treatment of bone marrow inhibition | |
| PL2444103T3 (pl) | Szczepionka przeciwko rakowi szyjki macicy | |
| PL2605764T3 (pl) | Kompozycje do leczenia nowotworu | |
| IL222958A0 (en) | Cancer treatment | |
| IL214349A0 (en) | Compositions and methods for the treatment of cancer | |
| ZA201208568B (en) | Skin treatment composition | |
| GB201718726D0 (en) | Phytocannabinoids in the treatment of cancer | |
| ZA201201894B (en) | Pharmaceutical combination for treating tumor | |
| PT2566506T (pt) | Composição de vacina para a prevenção ou tratamento de leishmanioses | |
| AU2011211693B2 (en) | Pharmaceutical composition for treating and/or preventing cancer |